San Francisco, 31 December 2018, Pediatric Vaccines Market Analysis By Type
(Monovalent, Multivalent), By Technology (Live Attenuated, Inactivated,
Subunit, Toxoid, Conjugate), By Application (Infectious Diseases, Cancer,
Allergy), By Region, And Segment Forecasts, 2018 – 2025
The global pediatric vaccines market is expected to reach USD
60.4 billion by 2025 at an 11.7% CAGR, according to a new report by Grand View
Research, Inc. Advancements in development of vaccines and new product launches
are some of the major drivers of the market.
Increase in investments by
companies to capture a larger market share is anticipated to propel growth.
Some of the factors attributed to increase in investment are high growth
prospects in the emerging market, immunization schedule mandated by doctors for
children, and awareness programs led by UNICEF, WHO, and other healthcare
organizations. Furthermore, increase in number of government initiatives for
raising awareness about immunization is expected to boost the market for
pediatric vaccines.
Advancements in development of
novel adjuvants and therapeutic vaccines are expected to drive growth during
the forecast period. Ongoing research in novel molecules targeted at specific
mechanisms of action in the body is aimed at providing immunity against fatal
diseases such as cancer and Zika virus disease. For instance, in June 2016,
Inovio Pharmaceuticals, Inc. announced the initiation of phase I clinical trial
for their Zika DNA vaccine named GLS-5700.
Access Full Research
Report On Pediatric Vaccines Market Analysis:
www.grandviewresearch.com/industry-analysis/pediatric-vaccine-market
www.grandviewresearch.com/industry-analysis/pediatric-vaccine-market
Further key findings from the report suggest:
·
The global pediatric vaccines
market was estimated at USD 22.4 billion in 2016 and is expected to grow with a
CAGR of 11.7% from 2017 to 2025
·
By type, monovalent emerged as
the largest segment due to factors such as high usage and increase in
initiatives for R&D activities supported by various governments
·
Conjugate vaccines formed the
dominant technology segment in terms of revenue in 2016. Higher adoption of
these vaccines and increase in prevalence of infectious diseases contribute to
its lead in the market for pediatric vaccines
·
By application, the cancer
segment is expected to witness the fastest growth with a CAGR of 12.6% owing to
increasing prevalence of cancer and rising need for immunization against the
disease
·
North America held the largest
revenue share in 2016. Its dominance in the market for pediatric vaccines is
owing to factors such as local presence of major players in the industry and
extensive R&D activities
·
The Asia Pacific region is anticipated
to witness lucrative growth over the next decade due to increase in prevalence
of infectious diseases and a large target population
·
Key players such as
GlaxoSmithKline plc; Pfizer, Inc.; SANOFI; and AstraZeneca dominated the global
market for pediatric vaccines in 2016.
Browse More Reports Of This Category By
Grand View Research At: www.grandviewresearch.com/industry/pharmaceuticals
Grand View Research has segmented the
global pediatric vaccines market on the basis of type, technology, application,
and region:
Type Outlook (Market Revenue in
USD Billion, 2014 - 2025)
·
Monovalent
·
Multivalent
Technology Outlook (Market
Revenue in USD Billion, 2014 - 2025)
·
Live Attenuated
·
Inactivated
·
Subunit
·
Toxoid
·
Conjugate
·
Others
Application Outlook (Market
Revenue in USD Billion, 2014 - 2025)
·
Infectious disease
·
Cancer
·
Allergy
Regional Outlook (Revenue, USD
Billion, 2014 - 2025)
·
North America
o
U.S.
o
Canada
·
Europe
o
Germany
o
U.K.
·
Asia Pacific
o
China
o
Japan
o
India
·
Latin America
o
Brazil
o
Mexico
·
Middle East & Africa
o
South Africa
Access Full Press Release of this Report:
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and
consulting company, registered in the State of California and headquartered in
San Francisco. The company provides syndicated research reports, customized
research reports, and consulting services. To help clients make informed
business decisions, we offer market intelligence studies ensuring relevant and
fact-based research across a range of industries, from technology to chemicals,
materials and healthcare.
For more information: www.grandviewresearch.com/
